Glycemic and lipid control in patients with diabetes at time of myocardial infarction.

Date publication

avril 2024

Journal

Annales pharmaceutiques francaises

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COTTIN Yves

Tous les auteurs :
Lacqua C, Adam H, Zeller M, Vadot L, Bichat F, Maza M, Cottin Y, Boulin M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38685473

Résumé

Cardiovascular risk is increased in patients with diabetes. Little is known about glycemic and lipid control in patients with diabetes. We aimed to assess glycemic and lipid controls in patients with diabetes at time of their myocardial infarction.

Mots clés

diabetes, glycemic control, lipid control, myocardial infarction, pharmacotherapy

Référence

Ann Pharm Fr. 2024 04 27;: